Principles of Repair and Grafting of Bone and Cartilage

Current Therapy in Oral and Maxillofacial Surgery

Volumn , Issue , 2012, Pages 19-26

  Aghaloo, Tara L ^a   Felsenfeld, Alan L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882833360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-2527-6.00004-9     Document Type: Chapter

References (145)

1. Converse JM Restoration of facial contour by bone grafts introduced through the oral cavity. Plast Reconstr Surg (1946) 1950, 6(4):295-300.
2. Boyne PJ Use of freeze-dried homogenous bone grafts in the surgical positioning of teeth. J Oral Surg (Chic) 1957, 15(3):231-237.
3. Boyne PJ, Losee FL Use of anorganic heterogenous bone in oral bony defects. U S Armed Forces Med J 1957, 8(6):789-794.
4. Losee FL, Boyne PJ Response of oral tissues to grafts of ethylenediamine-treated heterogeneous bone. Nature 1957, 179(4564):818.
5. Bauer TW, Muschler GF Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000, 371:10-27.
6. Naujoks C, Meyer U, Wiesmann HP, et al. Principles of cartilage tissue engineering in TMJ reconstruction. Head Face Med 2008, 4:3.
7. Vinatier C, Gauthier O, Masson M, et al. Nasal chondrocytes and fibrin sealant for cartilage tissue engineering. J Biomed Mater Res A 2009, 89(1):176-185.
8. Cohen MM Craniofacial disorders caused by mutations in homeobox genes MSX1 and MSX2. J Craniofac Genet Dev Biol 2000, 20(1):19-25.
9. Bardach J, Morris H Multidisciplinary management of cleft lip and palate 1990, WB Saunders, Philadelphia.
10. Buckwalter JA Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther 1998, 28(4):192-202.
11. Goldberg VM, Stevenson S The biology of bone grafts. Semin Arthroplasty 1993, 4(2):58-63.
12. van Gemert JT, van Es RJ, Van Cann EM, Koole R Nonvascularized bone grafts for segmental reconstruction of the mandible-A reappraisal. J Oral Maxillofac Surg 2009, 67(7):1446-1452.
13. Bouloux GF Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg 2009, 67(11):2497-2504.
14. Stratmann U, Schaarschmidt K, Santamaria P Morphometric investigation of condylar cartilage and disc thickness in the human temporomandibular joint: significance for the definition of ostearthrotic changes. J Oral Pathol Med 1996, 25(5):200-205.
15. Mitchell ME, Giza E, Sullivan MR Cartilage transplantation techniques for talar cartilage lesions. J Am Acad Orthop Surg 2009, 17(7):407-414.
16. Hupp J Wound repair. Contemporary oral and maxillofacial surgery 2003, 49-62. Mosby, St. Louis. L.E. Peterson, J.R. Hupp, M.R. Tucker (Eds.).
17. Einhorn TA The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 355(Suppl):S7-21.
18. Evans CH, Ghivizzani SC, Robbins PD Orthopedic gene therapy in 2008. Mol Ther 2009, 17(2):231-244.
19. Chiang H, Jiang CC Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc 2009, 108(2):87-101.
20. Vinatier C, Mrugala D, Jorgensen C, et al. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009, 27(5):307-314.
21. Hunziker EB, Kapfinger E, Geiss J The structural architecture of adult mammalian articular cartilage evolves by a synchronized process of tissue resorption and neoformation during postnatal development. Osteoarthritis Cartilage 2007, 15(4):403-413.
22. Hunziker EB Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002, 10(6):432-463.
23. Steinert AF, Noth U, Tuan RS Concepts in gene therapy for cartilage repair. Injury 2008, 39(Suppl 1):S97-113.
24. Baltzer AW, Lieberman JR Regional gene therapy to enhance bone repair. Gene Ther 2004, 11(4):344-350.
25. Costantino PD, Hiltzik D, Govindaraj S, Moche J Bone healing and bone substitutes. Facial Plast Surg 2002, 18(1):13-26.
26. Miyazaki M, Tsumura H, Wang JC, Alanay A An update on bone substitutes for spinal fusion. Eur Spine J 2009, 18(6):783-799.
27. Franceschi RT Biological approaches to bone regeneration by gene therapy. J Dent Res 2005, 84(12):1093-1103.
28. Canady JW, Zeitler DP, Thompson SA, Nicholas CD Suitability of the iliac crest as a site for harvest of autogenous bone grafts. Cleft Palate Craniofac J 1993, 30(6):579-581.
29. Frodel JL, Marentette LJ The coronal approach. Anatomic and technical considerations and morbidity. Arch Otolaryngol Head Neck Surg 1993, 119(2):201-207. discussion 140.
30. Frodel JL, Marentette LJ, Quatela VC, Weinstein GS Calvarial bone graft harvest. Techniques, considerations, and morbidity. Arch Otolaryngol Head Neck Surg 1993, 119(1):17-23.
31. Albrektsson T Repair of bone grafts. A vital microscopic and histological investigation in the rabbit. Scand J Plast Reconstr Surg 1980, 14(1):1-12.
32. Rawashdeh MA, Telfah H Secondary alveolar bone grafting: the dilemma of donor site selection and morbidity. Br J Oral Maxillofac Surg 2008, 46(8):665-670.
33. Bienek C, MacKay L, Scott G, et al. Development of a bacteriophage model system to investigate virus inactivation methods used in the treatment of bone allografts. Cell Tissue Bank 2007, 8(2):115-124.
34. Buck BE, Malinin TI, Brown MD Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 1989, 240:129-136.
35. Kappe T, Cakir B, Mattes T, et al. Infections after bone allograft surgery: a prospective study by a hospital bone bank using frozen femoral heads from living donors. Cell Tissue Bank 2010, 11(3):253-259.
36. Boyan BD, Ranly DM, McMillan J, et al. Osteoinductive ability of human allograft formulations. J Periodontol 2006, 77(9):1555-1563.
37. Hallman M, Thor A Bone substitutes and growth factors as an alternative/complement to autogenous bone for grafting in implant dentistry. Periodontol 2000 2008, 47:172-192.
38. Vaccaro AR, Chiba K, Heller JG, et al. Bone grafting alternatives in spinal surgery. Spine J 2002, 2(3):206-215.
39. Garofalo GS Autogenous, allogenetic and xenogenetic grafts for maxillary sinus elevation: literature review, current status and prospects. Minerva Stomatol 2007, 56(7-8):373-392.
40. Enneking WF, Mindell ER Observations on massive retrieved human allografts. J Bone Joint Surg Am 1991, 73(8):1123-1142.
41. Friedlaender GE Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res 1983, 174:58-68.
42. Block MS, Kent JN Sinus augmentation for dental implants: the use of autogenous bone. J Oral Maxillofac Surg 1997, 55(11):1281-1286.
43. Kretlow JD, Mikos AG 2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. AIChE J 2008, 54(12):3048-3067.
44. Scheller EL, Krebsbach PH, Kohn DH Tissue engineering: state of the art in oral rehabilitation. J Oral Rehabil 2009, 36(5):368-389.
45. Zaky SH, Cancedda R Engineering craniofacial structures: facing the challenge. J Dent Res 2009, 88(12):1077-1091.
46. Frazza EJ, Schmitt EE A new absorbable suture. J Biomed Mater Res 1971, 5(2):43-58.
47. Bessho K, Carnes DL, Cavin R, Ong JL Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 2002, 61(1):61-65.
48. Boyan BD, Lohmann CH, Somers A, et al. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999, 46(1):51-59.
49. Hollinger JO, Leong K Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 1996, 17(2):187-194.
50. Aghaloo T, Cowan CM, Chou YF, et al. Nell-1-induced bone regeneration in calvarial defects. Am J Pathol 2006, 169(3):903-915.
51. Aghaloo TL, Amantea CM, Cowan CM, et al. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo. J Orthop Res 2007, 25(11):1488-1497.
52. Cowan CM, Aghaloo T, Chou YF, et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 2007, 13(3):501-512.
53. Bottaro DP, Liebmann-Vinson A, Heidaran MA Molecular signaling in bioengineered tissue microenvironments. Ann N Y Acad Sci 2002, 961:143-153.
54. Geckeler K, Wacker R, Martini F, et al. Enhanced biocompatibility for SAOS-2 osteosarcoma cells by surface coating with hydrophobic epoxy resins. Cell Physiol Biochem 2003, 13(3):155-164.
55. Schneider GB, English A, Abraham M, et al. The effect of hydrogel charge density on cell attachment. Biomaterials 2004, 25(15):3023-3028.
56. Dadsetan M, Hefferan TE, Szatkowski JP, et al. Effect of hydrogel porosity on marrow stromal cell phenotypic expression. Biomaterials 2008, 29(14):2193-2202.
57. Fujii H, Kitazawa R, Maeda S, et al. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. Histochem Cell Biol 1999, 112(2):131-138.
58. Lee FY, Storer S, Hazan EJ, et al. Repair of bone allograft fracture using bone morphogenetic protein-2. Clin Orthop Relat Res 2002, 397:119-126.
59. Rundle CH, Miyakoshi N, Ramirez E, et al. Expression of the fibroblast growth factor receptor genes in fracture repair. Clin Orthop Relat Res 2002, 403:253-263.
60. Schmidmaier G, Wildemann B, Heeger J, et al. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1. Bone 2002, 31(1):165-172.
61. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99(15):9656-9661.
62. Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 2001, 29(4):323-330.
63. Reddi AH Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 2000, 6(4):351-359.
64. Iwata H, Sakano S, Itoh T, Bauer TW Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. Clin Orthop Relat Res 2002, 395:99-109.
65. Wozney JM Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) 2002, 27(16 Suppl 1):S2-8.
66. Yamaguchi A, Komori T, Suda T Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000, 21(4):393-411.
67. Gitelman SE, Kobrin MS, Ye JQ, et al. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994, 126(6):1595-1609.
68. Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992, 267(28):20352-20362.
69. Chung YI, Ahn KM, Jeon SH, et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 2007, 121(1-2):91-99.
70. Kamakura S, Nakajo S, Suzuki O, Sasano Y New scaffold for recombinant human bone morphogenetic protein-2. J Biomed Mater Res A 2004, 71(2):299-307.
71. Boyne PJ Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 2001, 83-A Suppl 1(Pt 2):S146-150.
72. Herford AS, Boyne PJ Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008, 66(4):616-624.
73. Dickinson BP, Ashley RK, Wasson KL, et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 2008, 121(1):209-217.
74. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005, 63(12):1693-1707.
75. Poh CK, Shi Z, Lim TY, et al. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010, 31(7):1578-1585.
76. Gerber HP, Ferrara N Angiogenesis and bone growth. Trends Cardiovasc Med 2000, 10(5):223-228.
77. Hiratsuka S, Minowa O, Kuno J, et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A 1998, 95(16):9349-9354.
78. Kanczler JM, Ginty PJ, White L, et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010, 31(6):1242-1250.
79. Kakudo N, Kusumoto K, Wang YB, et al. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Life Sci 2006, 79(19):1847-1855.
80. De la Riva B, Sanchez E, Hernandez A, et al. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 2010, 143(1):45-52.
81. Chen RR, Silva EA, Yuen WW, Mooney DJ Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007, 24(2):258-264.
82. Steed DL Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006, 117(7 Suppl):143S-149S. discussion 150S-151S.
83. Mandracchia VJ, Sanders SM, Frerichs JA The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis. Clin Podiatr Med Surg 2001, 18(1):189-209. viii.
84. Antoniades HN Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci U S A 1981, 78(12):7314-7317.
85. Marx R Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts. Tissue engineering: applications in maxillofacial surgery and periodontics 1999, 71-82. Quintessence, Chicago. S. Lynch, R. Genco, R. Marx (Eds.).
86. Park YJ, Ku Y, Chung CP, Lee SJ Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. J Control Release 1998, 51(2-3):201-211.
87. Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997, 68(12):1186-1893.
88. Basilico C, Moscatelli D The FGF family of growth factors and oncogenes. Adv Cancer Res 1992, 59:115-165.
89. Gong Z, Zhou S, Cao J, Gu X Effects of recombinant human basic fibroblast growth factor on cell proliferation during mandibular fracture healing in rabbits. Chin J Traumatol 2001, 4(2):110-112.
90. Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994, 135(2):774-781.
91. Maehara H, Sotome S, Yoshii T, et al. Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2). J Orthop Res 2010, 28(5):677-686.
92. Mohan S, Baylink DJ Bone growth factors. Clin Orthop Relat Res 1991, 263:30-48.
93. Shen FH, Visger JM, Balian G, et al. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma 2002, 16(9):651-659.
94. Thaller SR, Lee TJ, Armstrong M, et al. Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats. J Craniofac Surg 1995, 6(3):218-223.
95. Lamberg A, Bechtold JE, Baas J, et al. Effect of local TGF-beta1 and IGF-1 release on implant fixation: comparison with hydroxyapatite coating. Acta Orthop 2009, 80(4):499-504.
96. Jung RE, Weber FE, Thoma DS, et al. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin Oral Implants Res 2008, 19(2):188-195.
97. Kempen DH, Lu L, Hefferan TE, et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29(22):3245-3252.
98. Takahashi Y, Yamamoto M, Yamada K, et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007, 13(2):293-300.
99. Salinas CN, Anseth KS Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles. J Dent Res 2009, 88(8):681-692.
100. Karageorgiou V, Meinel L, Hofmann S, et al. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 2004, 71(3):528-537.
101. Zhang Y, Shi B, Li C, et al. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. J Control Release 2009, 136(3):172-178.
102. Young S, Patel ZS, Kretlow JD, et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 2009, 15(9):2347-2362.
103. Stefani CM, Machado MA, Sallum EA, et al. Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs. Implant Dent 2000, 9(2):126-131.
104. Huang GT, Gronthos S, Shi S Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 2009, 88(9):792-806.
105. Panetta NJ, Gupta DM, Quarto N, Longaker MT Mesenchymal cells for skeletal tissue engineering. Panminerva Med 2009, 51(1):25-41.
106. De Kok IJ, Drapeau SJ, Young R, Cooper LF Evaluation of mesenchymal stem cells following implantation in alveolar sockets: a canine safety study. Int J Oral Maxillofac Implants 2005, 20(4):511-518.
107. Yamada Y, Ueda M, Hibi H, Nagasaka T Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 2004, 13(4):343-355.
108. Weng Y, Wang M, Liu W, et al. Repair of experimental alveolar bone defects by tissue-engineered bone. Tissue Eng 2006, 12(6):1503-1513.
109. Chang SC, Wei FC, Chuang H, et al. Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast Reconstr Surg 2003, 112(7):1841-1850.
110. Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999, 81(7):905-917.
111. Dai KR, Xu XL, Tang TT, et al. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005, 77(1):55-61.
112. Evans CH, Palmer GD, Pascher A, et al. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 2007, 13(8):1987-1993.
113. Moreau JL, Caccamese JF, Coletti DP, et al. Tissue engineering solutions for cleft palates. J Oral Maxillofac Surg 2007, 65(12):2503-2511.
114. Shayesteh YS, Khojasteh A, Soleimani M, et al. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106(2):203-209.
115. Tu Q, Valverde P, Li S, et al. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 2007, 13(10):2431-2440.
116. Rotter N, Haisch A, Bucheler M Cartilage and bone tissue engineering for reconstructive head and neck surgery. Eur Arch Otorhinolaryngol 2005, 262(7):539-545.
117. Richter W Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med 2009, 266(4):390-405.
118. Knutsen G, Drogset JO, Engebretsen L, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007, 89(10):2105-2112.
119. Steinwachs MR, Guggi T, Kreuz PC Marrow stimulation techniques. Injury 2008, 39(Suppl 1):S26-31.
120. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331(14):889-895.
121. Marlovits S, Zeller P, Singer P, et al. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 2006, 57(1):24-31.
122. van Osch GJ, Brittberg M, Dennis JE, et al. Cartilage repair: past and future-Lessons for regenerative medicine. J Cell Mol Med 2009, 13(5):792-810.
123. Baragi VM, Renkiewicz RR, Qiu L, et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthritis Cartilage 1997, 5(4):275-282.
124. Goto H, Shuler FD, Lamsam C, et al. Transfer of lacZ marker gene to the meniscus. J Bone Joint Surg Am 1999, 81(7):918-925.
125. Mason JM, Breitbart AS, Barcia M, et al. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin Orthop Relat Res 2000, 379(Suppl):S171-178.
126. Hidaka C, Goodrich LR, Chen CT, et al. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res 2003, 21(4):573-583.
127. Li Y, Tew SR, Russell AM, et al. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng 2004, 10(3-4):575-584.
128. Shuler FD, Georgescu HI, Niyibizi C, et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 2000, 18(4):585-592.
129. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005, 52(8):2521-2529.
130. Vacanti CA, Paige KT, Kim WS, et al. Experimental tracheal replacement using tissue-engineered cartilage. J Pediatr Surg 1994, 29(2):201-204. discussion 204-205.
131. Kamil SH, Vacanti MP, Aminuddin BS, et al. Tissue engineering of a human sized and shaped auricle using a mold. Laryngoscope 2004, 114(5):867-870.
132. Puelacher WC, Mooney D, Langer R, et al. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Biomaterials 1994, 15(10):774-778.
133. Puelacher WC, Wisser J, Vacanti CA, et al. Temporomandibular joint disc replacement made by tissue-engineered growth of cartilage. J Oral Maxillofac Surg 1994, 52(11):1172-1177. discussion 1177-1178.
134. Ahmed N, Dreier R, Gopferich A, et al. Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells. Cell Physiol Biochem 2007, 20(5):665-678.
135. Hwang NS, Varghese S, Puleo C, et al. Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J Cell Physiol 2007, 212(2):281-284.
136. Angele P, Schumann D, Angele M, et al. Cyclic, mechanical compression enhances chondrogenesis of mesenchymal progenitor cells in tissue engineering scaffolds. Biorheology 2004, 41(3-4):335-346.
137. Steck E, Fischer J, Lorenz H, et al. Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage. Stem Cells Dev 2009, 18(7):969-978.
138. Asanbaeva A, Masuda K, Thonar EJ, et al. Mechanisms of cartilage growth: modulation of balance between proteoglycan and collagen in vitro using chondroitinase ABC. Arthritis Rheum 2007, 56(1):188-198.
139. McMahon LA, Reid AJ, Campbell VA, Prendergast PJ Regulatory effects of mechanical strain on the chondrogenic differentiation of MSCs in a collagen-GAG scaffold: experimental and computational analysis. Ann Biomed Eng 2008, 36(2):185-194.
140. Terraciano V, Hwang N, Moroni L, et al. Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels. Stem Cells 2007, 25(11):2730-2738.
141. Koga H, Muneta T, Ju YJ, et al. Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration. Stem Cells 2007, 25(3):689-696.
142. Park H, Temenoff JS, Tabata Y, et al. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007, 28(21):3217-3227.
143. Sharma B, Elisseeff JH Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng 2004, 32(1):148-159.
144. Cohen NP, Foster RJ, Mow VC Composition and dynamics of articular cartilage: structure, function, and maintaining healthy state. J Orthop Sports Phys Ther 1998, 28(4):203-215.
145. Lumelsky NL Commentary: engineering of tissue healing and regeneration. Tissue Eng 2007, 13(7):1393-1398.